Hengning Ke
- Co-authors
- Wufan TaoJohn E. FrenchJennifer ZhangXiaoqing LiLingling LiuYubin LeiXiaofeng ChenShicheng Guo
- Topics
- COVID-19 Clinical Research Studies (5 papers)Long-Term Effects of COVID-19 (4 papers)RNA modifications and cancer (3 papers)
- Journals
- Journal of Biological ChemistrySHILAP Revista de lepidopterologíaCancer Research
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Hengning Ke
16 papers receiving 434 citations
Peers
Comparison fields: 5 of 75
- Molecular Biology 289
- Cancer Research 112
- Oncology 100
- Cell Biology 83
- Health, Toxicology and Mutagenesis 36
Countries citing papers authored by Hengning Ke
This map shows the geographic impact of Hengning Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hengning Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hengning Ke more than expected).
Fields of papers citing papers by Hengning Ke
This network shows the impact of papers produced by Hengning Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hengning Ke. The network helps show where Hengning Ke may publish in the future.
Co-authorship network of co-authors of Hengning Ke
This figure shows the co-authorship network connecting the top 25 collaborators of Hengning Ke. A scholar is included among the top collaborators of Hengning Ke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hengning Ke. Hengning Ke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 9 | |
| 3 | 16 | |
| 4 | 4 | |
| 5 | 12 | |
| 6 | 2 | |
| 7 | 15 | |
| 8 | 7 | |
| 9 | 5 | |
| 10 | 4 | |
| 11 | 127 | |
| 12 | 22 | |
| 13 | 9 | |
| 14 | 47 | |
| 15 | 37 | |
| 16 | 44 | |
| 17 | 78 |
About Hengning Ke
Hengning Ke is a scholar working on Infectious Diseases, Neurology and Cancer Research, having authored 17 papers that have together received 438 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (5 papers), Long-Term Effects of COVID-19 (4 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Cancer Research (112 citations), Cell Biology (83 citations) and Molecular Biology (289 citations). Hengning Ke has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Wufan Tao, John E. French, Jennifer Zhang, Xiaoqing Li, Lingling Liu, Yubin Lei, Xiaofeng Chen, Shicheng Guo, Jiucun Wang and Bo Su. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.